# Session self-evaluation — `SLR-scientist-b-0004`

**Actor:** `scientist-b` · **Task:** `AQEILAN-FT-B-001`, wave 4 · **Date:** 2026-09-09
**Scope of the wave:** one item — pay the wave-3 reading debt on **PMID 38499540** by minting a
manifest and a receipt, re-verifying rather than inheriting. `27551470` was **not started**.
**Written BEFORE any closing report**, per the protocol's order of operations.

---

## Part 1 — executable verdicts (run first, not answered)

| Check | Verdict |
|---|---|
| `session_self_eval.py --disease wwox` | **PASS** — 141 receipts, 72 complete events, 61 active complete reads. No `[DECLARED GAP]` on 38499540. |
| `deepdive_manifest.py --pmid 38499540 --verify-artifacts --require-current-schema` | **PASS**, 0 gaps, 34 locators / 14 artifacts, SHA-256 and exact text verified |
| `fulltext_receipts.py verify` | **OK** — 141 chained, tail anchored |
| `legend_lint.py .` | **PASS** (one pre-existing INFO on CLAIM 010, not mine) |
| `growth_anchors.py check` | **PASS**; `[IMPROVED]` registry-only 15 → 14 — **not mine**, see Q17 |

---

## Part 2 — judgement

### Reading (Q1–Q3)

**Q1 — section by section, figures as images, tables?** Partly this wave and partly wave 3, and
the split is the honest weak point of the whole claim, so it goes first rather than last. The
*sequential prose* pass (Introduction, Methods, Results, Discussion) was performed in **wave 3**,
same actor, same task, same calendar day. Wave 4 did **not** re-read Methods sequentially. What
wave 4 did do is re-establish every surface a locator stands on: all 9 body snippets re-matched
character-for-character against the current XML (**9 exact / 0 miss / 0 abstract**), all six main
figures re-opened as images at native resolution, all six deposited supplement images opened, the
MOESM3 legends read as a verified `.docx` surface and the MOESM2 chart read by EMF text-record
parse. Tables are `not_present` by **element count** (0 `table-wrap`), not by impression;
references are 73 by element count. *Bad answer avoided:* "the recipe said no re-reading was
required." It did, and it was treated as a convenience and never as a licence.

**Q2 — read against the grain of the disease label?** Yes, and it is the main reason the reading
is worth anything to this repository. The paper is mammary oncology; the disease model is a
CNS encephalopathy. The transfer verdict is `ESPANSIONE` and the premise that would license
transfer — *"a DSB-repair-choice function measured in mammary epithelium describes the same
function in post-mitotic neurons"* — is tagged `PREMISE: DEFAULT_FROM_TEXTBOOK` and marked
provisional by construction, because HDR requires S/G2 and the paper's own Introduction says so.

**Q3 — what would a keyword search not have returned?** Three things, none of them keyword-shaped.
(a) Three of six figure **caption titles assert the opposite of their own panels** while body,
headings and graphical abstract are correct — visible only by opening the images. (b) Fig 3D's
`**` is **not supported by the three values the panel plots** (pooled *t* = 2.797, df 4,
**P = 0.049**; Welch 0.105; paired 0.113) and the drawn error bar is the **SD** where the caption
declares **SEM** — visible only by measuring pixels. (c) The unit of statistical analysis is
**fields, not mice**, disclosed only in a PowerPoint **speaker-notes pane** in Hebrew.

### Group and field (Q4–Q7)

**Q4/Q5** — Aqeilan laboratory, `Aqeilan RI[au]` = 137, `AND WWOX` = 65 (re-measured 2026-09-09,
unchanged). Experimental lab, mouse genetics plus human TNBC lines. **Primary for the gene, NOT
for the disease** — recorded explicitly in `group_assessment`, and the weighting follows: high
weight on the mouse genetics and foci quantifications, low transfer to the CNS phenotype.

**Q6 — did group inexperience predict a specific error?** No, and the honest shape here is the
opposite: this is a highly experienced lab and the failures are **presentational**, concentrated
in headline surfaces (caption titles) while the science underneath is internally consistent. That
is the second consecutive paper from this laboratory with that exact shape — PMID 38182577 carries
a published *title* that inverts its own body. Group inexperience predicted nothing; group **house
style** predicted the surface that failed.

**Q7 — intersection size?** `WWOX AND BRCA1` = **14 records in all of PubMed**;
`WWOX AND (NHEJ OR "homologous recombination" OR "DNA repair")` = 28. A sparse field, which is why
a single adversarial finding on Fig 3D matters more than it would in a dense one.

### Epistemic discipline (Q8–Q10)

**Q8/Q9 — shows versus claims.** This is the whole product of the reading. The manifest carries
**four contradiction pairs and one qualification**, each as a *panel* locator pointing at a *text*
locator with a needle drawn from the target's snippet — never text contradicting text wearing the
word "panel" (open item 4). Where the tension genuinely **is** text-versus-text — the running
text's normal-vs-tumour elevation against its own legends' "not significant" — both sides are
declared `text_only` and the proposition says so explicitly.

**Q10 — extraction fault or author error?** Distinguished, and it changed a verdict. Sup Fig 2's
legend prints `Pvalue >0.05` where every main legend prints `P value < 0.05`. Rather than report a
reversed threshold as a result statement, I parsed the deposited EMF chart's own text records:
they print `ns, ns, ns, **, ns, ***, ns`. A legend declaring `>0.05` beside a chart carrying `**`
and `***` cannot be a result statement, so it is typed as a **transcription defect**. Wave 3
inferred this; wave 4 measured it.

### Persistence and horizontal reach (Q11–Q15)

**Q11 — append-only ledger or staging?** Ledger. `FTR-20260909-38499540-02`, appended through the
validated writer, never by hand; 141 chained, tail re-anchored. The wave-3 state was
`ANALYSIS_DONE_RECEIPT_NOT_PERSISTED` and it is now closed by a receipt rather than by an assertion.

**Q12 — multi-hop?** **No, and I nearly claimed otherwise.** This is the finding of this
self-evaluation. My manifest edit flipped `multihop.performed` from `false` to `true` while wave 4
performed **no new multi-hop work** — correcting a reference count by element count is not an
expansion. The self-evaluation caught it *before* any closing report; the flag was reverted to
`false` with a note recording that it was flipped and why it was put back, and the fix is committed.
Ref 17 (Park et al.), the study this paper claims alignment with, remains the highest-value
unresolved hop.

**Q13 — corpus cross-query?** Yes, and it returned one hit that is a pattern, not a coincidence:
PMID 38182577, same laboratory, same headline-surface defect one level up.

**Q14 — which existing claim?** `CLAIM 029` (WWOX contributes to DDR competence via ATM, status
`in observation`, source PMID 25331887) — **neither narrowed nor corroborated**, and said so
explicitly. This paper is not its source and names 25331887 as an acknowledged *conflict*; wave 4
weakens **this** paper's own in vitro evidence for the opposite direction, which leaves that
published disagreement **more open, not less**. No `consolidated baseline` claim is touched; the
`legend-locator-audit` threshold was checked against the registry and **not met**, recorded so the
non-trigger is auditable.

**Q15 — reading debt written into the queue?** Yes. `FT-051` closed in
`full_text_queue_current.md` with the wave-4 record, not merely mentioned in prose.

### Capability (Q16–Q19)

**Q16/Q17 — what grew, what broke?** See the micro-upgrade below. Nothing broke in the run. One
thing was **observed and deliberately not fixed**: `growth_anchors.py` reports the registry-only
ratchet fell 15 → 14 and asks for a re-anchor. I checked whether it was mine: 38499540 is only a
`CORPUS-STUB` in the paper registry, not a record declaring "full text reviewed", so **my receipt
did not cause the fall**; the last anchor event is dated 2026-08-14 and the drop happened since,
through another actor's back-fill. `tighten` requires a `--note` whose declared value *is the
reasoning*, and I cannot honestly supply reasoning for a resolution that is not mine. **Reported,
not fixed** — the standing rule for cross-actor state.

**Q18 — did a check catch me?** Yes, twice, and both are worth naming because they are the useful
signal. (a) The strict validator refused entry 26 for carrying `qualifies` without a
`qualifies_needle` — its message is exactly right: a bare list position can be silently redirected
by an insertion while every other check still passes. I supplied the needle rather than weakening
anything. (b) **My own self-evaluation caught the `multihop.performed` flip** (Q12) and a stale
"55 entries" sentence sitting two fields below the corrected `73`. Neither was caught by a peer or
the operator, which is worth stating plainly: the attribution here is the process, not a reviewer.

**Q19 — ranking versus judgement?** The dossier's §8 recipe is a form of ranking — it told me what
to do and in what order. I diverged from it twice and recorded both: step 3's `legend-locator-audit`
was **not** invoked (threshold checked, not met, and no commit candidate was built on §3.1), and
step 2's `.pptx` decision went to *declare the debt* rather than build under the same breath as the
mint. Both divergences are written into §8 itself rather than left in a transcript.

### Substance and provenance (Q20–Q25)

**Q20 — main message, original contribution, hidden gold.** *Message:* combined Wwox/Brca1 loss in
basal mammary epithelium produces basal-like tumours and shifts DSB repair away from NHEJ.
*Contribution:* the mouse genetics — `Brca1` loss alone produces no tumours in the window observed,
and one `Trp53` null allele shortens median latency 495 → 268 days. *Hidden gold:* the supplement.
Sup Fig 1D shows **no p53 transcript at all** in the `Trp53^+/fl` tumour lane and Sup Fig 1C
corroborates with a P53-negative tumour on an independent surface — so the acceleration is
associated with **categorical** p53 loss, not haploinsufficiency, and the article states only the
latency change.

**Q21 — source parity on two axes?** Study type: primary experimental work, weighted as such —
mouse genetics and foci counts weighted high, the SeeSaw outcome measure weighted **down** because
its HDR arm sits at 0.03–0.83 % of events in every condition, i.e. a null measured at the assay
floor. Team axis: primary-for-gene, not-primary-for-disease, applied as a weighting and not as a
discount.

**Q22 — team classification?** `primary disease group` for **WWOX the gene**; explicitly **not**
for WWOX-DEE clinical phenotype. Recorded in `group_assessment.is_primary_group_for_disease: false`.

**Q23 — skills used and declined.** Used: `legend-session-self-eval` (this document — an obligation
flagged unmet in wave 3 and met here). Declined with reasons carried in `skills_considered`:
`legend-deepdive` (the central findings are disagreements between captions and their own panels,
which a read-only sub-agent cannot see); `legend-locator-audit` (threshold checked against the
registry and not met, and nothing was promoted on §3.1); `legend-hypothesis-forge` and
`legend-safety-triage` (no molecule and no therapeutic lever matured here — this is `ESPANSIONE`
outside the WWOX-DEE domain).

**Q24 — where did output land?** Manifest, receipt ledger, dossier, queue — four durable surfaces,
all committed. **No commit candidate**, deliberately: nothing may be promoted on the un-audited
adversarial finding of §3.1, and the four current files are untouched.

**Q25 — can the next run answer mechanically?** Yes. Full text, not abstract; 2026-09-09;
`files/fulltext/PMID38499540_BidanyMizrahi2024_PMC.xml`, sha256 `3805c70b…`, named in the receipt's
`source_fingerprint`, with 14 artifacts fingerprinted in the manifest.

### Friction and transferable delta (Q26–Q27)

**Q26 — friction.** One schema rejection (the `qualifies_needle`, above — correct and useful). One
structural refusal that is **not** friction but a genuine capability gap: `ARTIFACT_KINDS` is
`{article_binary, article_text, supplement_text, figure, table}` with **no binary supplement kind**,
and `_artifact_text` has no `.pptx` branch — so a `.pptx` is declarable only as `supplement_text`,
which its own text verification then refuses. This is **wider than §7 of the dossier recorded**: §7
said the containers were unreadable; they are in fact **undeclarable**. Consequence: the single most
consequential sentence in the reading (Q3c) is carried in the dossier only and **not** mislabelled
as a `figure`.

**Q27 — transferable capability delta.** Disease-agnostic and gene-agnostic: see below.

---

## Weakest answer, and the proportional micro-upgrade

**Weakest answer: Q1** — the depth claim rests on a prose pass performed in a previous session,
re-verified surface-by-surface but not re-read sequentially. Second weakest: **Q12**, where I
flipped a flag I had not earned.

The upgrade is derived from Q12/Q18 rather than from Q1, because Q1's remedy (re-read everything
every wave) is not proportional and would not generalise, whereas Q12's remedy does: **nothing in
the toolchain would have caught the `multihop.performed` flip.** The validator checks that the key
exists, never that its value is earned. A flag that silently improves between two edits of the same
manifest is invisible to every check in this repository, and it is exactly the class of defect this
protocol was written for — a plausible predicate answering a different question from the one asked.

**Micro-upgrade shipped:** `framework/scripts/manifest_flag_drift.py` — see the closing report. It
compares a manifest against its own git history and reports any **monotonic self-improvement** of a
declared-effort flag (`multihop.performed`, `group_assessment.performed`, `field_density.performed`,
`corpus_crossquery.performed`, `retraction_check.performed`, and `verbatim_locators.waived` turning
off) that lands in the same commit range without a corresponding note. It is disease-agnostic,
gene-agnostic and read-only.

---

## Verdict

**Process: PASS with one self-caught defect.** The wave delivered exactly what it was dispatched to
deliver, the depth claimed is the depth the evidence earns, two gaps are declared rather than
papered over, and the one unearned improvement was found by this diagnosis before any report was
written — which is the entire argument for running it first.

**Content: sound, and one finding deliberately unpromoted.** §3.1 is an adversarial claim against a
published significance mark. It is now measured twice, by two independent methods, and it is still
**not** promoted to a commit candidate, because a blind locator audit is its correct next gate.
